Enantioselective Intermolecular Radical Amidation and Amination of Benzylic C− H Bonds via Dual Copper and Photocatalysis

X Chen, Z Lian, S Kramer - Angewandte Chemie International …, 2023 - Wiley Online Library
A method for direct access to enantioenriched benzylic amides and carbamate‐protected
primary benzylamines by C− H functionalization is reported. The C− H substrate is used as …

[HTML][HTML] Potential inhibitors targeting papain-like protease of SARS-CoV-2: two birds with one stone

H Jiang, P Yang, J Zhang - Frontiers in chemistry, 2022 - frontiersin.org
Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), the pathogen of the
Coronavirus disease-19 (COVID-19), is still devastating the world causing significant chaos …

Validation and invalidation of SARS-CoV-2 papain-like protease inhibitors

C Ma, J Wang - ACS pharmacology & translational science, 2022 - ACS Publications
SARS-CoV-2 encodes two viral cysteine proteases, the main protease (Mpro) and the
papain-like protease (PLpro), both of which are validated antiviral drug targets. PLpro is …

[HTML][HTML] Drugs for COVID-19: An update

J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …

Active learning guided drug design lead optimization based on relative binding free energy modeling

F Gusev, E Gutkin, MG Kurnikova… - Journal of Chemical …, 2023 - ACS Publications
In silico identification of potent protein inhibitors commonly requires prediction of a ligand
binding free energy (BFE). Thermodynamics integration (TI) based on molecular dynamics …

[HTML][HTML] Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease

V Srinivasan, H Brognaro, PR Prabhu… - Communications …, 2022 - nature.com
Abstract SARS-CoV-2 papain-like protease (PLpro) covers multiple functions. Beside the
cysteine-protease activity, facilitating cleavage of the viral polypeptide chain, PLpro has the …

[HTML][HTML] Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal

K Nepali, R Sharma, S Sharma, A Thakur… - Journal of Biomedical …, 2022 - Springer
Unprecedented efforts of the researchers have been witnessed in the recent past towards
the development of vaccine platforms for the control of the COVID-19 pandemic. Albeit …

Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease Mpro and Papain-like Protease PLpro of SARS-CoV-2

LH Santos, T Kronenberger, RG Almeida… - Journal of Chemical …, 2022 - ACS Publications
The worldwide COVID-19 pandemic caused by the coronavirus SARS-CoV-2 urgently
demands novel direct antiviral treatments. The main protease (Mpro) and papain-like …

[HTML][HTML] A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2

K Sargsyan, K Mazmanian, C Lim - Scientific Reports, 2023 - nature.com
Alterations in viral fitness cannot be inferred from only mutagenesis studies of an isolated
viral protein. To-date, no systematic analysis has been performed to identify mutations that …

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

B Tan, X Zhang, A Ansari, P Jadhav, H Tan, K Li… - Science, 2024 - science.org
The emergence of SARS-CoV-2 variants and drug-resistant mutants calls for additional oral
antivirals. The SARS-CoV-2 papain-like protease (PLpro) is a promising but challenging …